Rifaximin improves the prognosis of liver cirrhosis;Rifaximin verbessert die prognose der leberzirrhose

MMW-Fortschritte der Medizin

Volumn 156, Issue 14, 2014, Pages 35-

  Fuessl H S ^a  

^a Innere Medizin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADMINISTRATION, ORAL; CONTROLLED CLINICAL TRIALS AS TOPIC; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS, ALCOHOLIC; RIFAMYCINS;

EID: 84906859908     PISSN: 14383276     EISSN: 16133560     Source Type: Journal    
DOI: 10.1007/s15006-014-3335-9     Document Type: Note

References (1)

1. J. Vlachogiannakos et al. (Korres.: jvlachog@hotmail.com): Lomg-term administration of Rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis. J Gastroenterol Hepatol 2013;28:450-455